" class="no-js "lang="en-US"> Companies Archive - Page 14 of 145 - Medtech Alert
Wednesday, September 17, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
1448 Results.

View Company

 Prolifagen Therapeutics | Pharmtech Focus

Prolifagen Therapeutics

View Company

 Vyriad | Pharmtech Focus

Vyriad

View Company

 Whitelab Genomics | Pharmtech Focus

Whitelab Genomics

View Company

 Debiopharm Innovation Fund | Pharmtech Focus

Debiopharm Innovation Fund

View Company

 Neurolens | Pharmtech Focus

Neurolens

View Company

 BioIVT | Pharmtech Focus

BioIVT

View Company

 XenoTech | Pharmtech Focus

XenoTech

View Company

 SeekIn | Pharmtech Focus

SeekIn

View Company

 Clinica | Universidad de Navarra Pharmtech Focus

Clinica Universidad de Navarra

View Company

 Redbud Medicine | Pharmtech Focus

Redbud Medicine

Load More Results